Skip to main content
Have a personal or library account? Click to login
Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? Cover

Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Radiology and Oncology
Volume 56 (2022): Issue 2 (June 2022)
By: Dorota Maria Borowicz,  Agnieszka Skrobała,  Marta Kruszyna-Mochalska and  Julian Malicki  
Open Access
|Mar 2022
Metrics

Metrics

DOI: https://doi.org/10.2478/raon-2022-0010 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 259 - 266
Submitted on: Oct 21, 2021
Accepted on: Jan 31, 2022
Published on: Mar 28, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostate carcinoma,
stereotactic radiotherapy,
intensity-modulated radiotherapy,
CyberKnife
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 56 (2022): Issue 2 (June 2022)
Previous article